Cargando…

Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) contributes to the global epidemic of metabolic syndrome and is considered a prelude to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. During NAFLD pathogenesis, hepatic parenchymal cells (hepatocytes) undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yan, Miao, Xiulian, Sun, Xinyue, Li, Luyang, Zhou, Anqi, Zhu, Xi, Xu, Yong, Wang, Qinghua, Li, Zilong, Fan, Zhiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206499/
https://www.ncbi.nlm.nih.gov/pubmed/37234276
http://dx.doi.org/10.1016/j.jhepr.2023.100724
_version_ 1785046243821486080
author Guo, Yan
Miao, Xiulian
Sun, Xinyue
Li, Luyang
Zhou, Anqi
Zhu, Xi
Xu, Yong
Wang, Qinghua
Li, Zilong
Fan, Zhiwen
author_facet Guo, Yan
Miao, Xiulian
Sun, Xinyue
Li, Luyang
Zhou, Anqi
Zhu, Xi
Xu, Yong
Wang, Qinghua
Li, Zilong
Fan, Zhiwen
author_sort Guo, Yan
collection PubMed
description BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) contributes to the global epidemic of metabolic syndrome and is considered a prelude to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. During NAFLD pathogenesis, hepatic parenchymal cells (hepatocytes) undergo both morphological and functional changes owing to a rewired transcriptome. The underlying mechanism is not entirely clear. In the present study, we investigated the involvement of early growth response 1 (Egr1) in NAFLD. METHODS: Quantitative PCR, Western blotting, and histochemical staining were used to assess gene expression levels. Chromatin immunoprecipitation was used to evaluate protein binding to DNA. NAFLD was evaluated in leptin receptor-deficient (db/db) mice. RESULTS: We report here that Egr1 was upregulated by pro-NAFLD stimuli in vitro and in vivo. Further analysis revealed that serum response factor (SRF) was recruited to the Egr1 promoter and mediated Egr1 transactivation. Importantly, Egr1 depletion markedly mitigated NAFLD in db/db mice. RNA sequencing revealed that Egr1 knockdown in hepatocytes, on the one hand, boosted fatty acid oxidation (FAO) and, on the other hand, suppressed the synthesis of chemoattractants. Mechanistically, Egr1 interacted with peroxisome proliferator-activated receptor α (PPARα) to repress PPARα-dependent transcription of FAO genes by recruiting its co-repressor NGFI-A binding protein 1 (Nab1), which potentially led to promoter deacetylation of FAO genes. CONCLUSIONS: Our data identify Egr1 as a novel modulator of NAFLD and a potential target for NAFLD intervention. IMPACT AND IMPLICATIONS: Non-alcoholic fatty liver disease (NAFLD) precedes cirrhosis and hepatocellular carcinoma. In this paper, we describe a novel mechanism whereby early growth response 1 (Egr1), a transcription factor, contributes to NAFLD pathogenesis by regulating fatty acid oxidation. Our data provide novel insights and translational potential for NAFLD intervention.
format Online
Article
Text
id pubmed-10206499
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102064992023-05-25 Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease Guo, Yan Miao, Xiulian Sun, Xinyue Li, Luyang Zhou, Anqi Zhu, Xi Xu, Yong Wang, Qinghua Li, Zilong Fan, Zhiwen JHEP Rep Research Article BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) contributes to the global epidemic of metabolic syndrome and is considered a prelude to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. During NAFLD pathogenesis, hepatic parenchymal cells (hepatocytes) undergo both morphological and functional changes owing to a rewired transcriptome. The underlying mechanism is not entirely clear. In the present study, we investigated the involvement of early growth response 1 (Egr1) in NAFLD. METHODS: Quantitative PCR, Western blotting, and histochemical staining were used to assess gene expression levels. Chromatin immunoprecipitation was used to evaluate protein binding to DNA. NAFLD was evaluated in leptin receptor-deficient (db/db) mice. RESULTS: We report here that Egr1 was upregulated by pro-NAFLD stimuli in vitro and in vivo. Further analysis revealed that serum response factor (SRF) was recruited to the Egr1 promoter and mediated Egr1 transactivation. Importantly, Egr1 depletion markedly mitigated NAFLD in db/db mice. RNA sequencing revealed that Egr1 knockdown in hepatocytes, on the one hand, boosted fatty acid oxidation (FAO) and, on the other hand, suppressed the synthesis of chemoattractants. Mechanistically, Egr1 interacted with peroxisome proliferator-activated receptor α (PPARα) to repress PPARα-dependent transcription of FAO genes by recruiting its co-repressor NGFI-A binding protein 1 (Nab1), which potentially led to promoter deacetylation of FAO genes. CONCLUSIONS: Our data identify Egr1 as a novel modulator of NAFLD and a potential target for NAFLD intervention. IMPACT AND IMPLICATIONS: Non-alcoholic fatty liver disease (NAFLD) precedes cirrhosis and hepatocellular carcinoma. In this paper, we describe a novel mechanism whereby early growth response 1 (Egr1), a transcription factor, contributes to NAFLD pathogenesis by regulating fatty acid oxidation. Our data provide novel insights and translational potential for NAFLD intervention. Elsevier 2023-03-09 /pmc/articles/PMC10206499/ /pubmed/37234276 http://dx.doi.org/10.1016/j.jhepr.2023.100724 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Guo, Yan
Miao, Xiulian
Sun, Xinyue
Li, Luyang
Zhou, Anqi
Zhu, Xi
Xu, Yong
Wang, Qinghua
Li, Zilong
Fan, Zhiwen
Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
title Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
title_full Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
title_fullStr Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
title_full_unstemmed Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
title_short Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
title_sort zinc finger transcription factor egf1 promotes non-alcoholic fatty liver disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206499/
https://www.ncbi.nlm.nih.gov/pubmed/37234276
http://dx.doi.org/10.1016/j.jhepr.2023.100724
work_keys_str_mv AT guoyan zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT miaoxiulian zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT sunxinyue zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT liluyang zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT zhouanqi zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT zhuxi zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT xuyong zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT wangqinghua zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT lizilong zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease
AT fanzhiwen zincfingertranscriptionfactoregf1promotesnonalcoholicfattyliverdisease